comparemela.com

Latest Breaking News On - Prayasvinb patel - Page 1 : comparemela.com

This Vijay Kedia-backed stock zoom 10% today; 3 reasons behind today s sharp rise

Elecon Engineering reports Q3 FY24 results, shares dip - The Hindu BusinessLine

Elecon Engineering reports Q3 FY24 results, shares dip - The Hindu BusinessLine
thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.

Multibagger stock: Elecon Engineering shares spurt 18% on upbeat Q1 results

Elecon Engineering shares soared 18.39 per cent to hit a high of Rs 748 on BSE. With this, the one year return for the multibagger stock jumped to 122 per cent.

India Inc prepares to fight 2nd wave of Covid: Mi India pledges Rs 3 cr; Cashkaro boss asks people for support

Pain, grief and sorrow are the only emotions emerging from India. The second wave of coronavirus pandemic has gripped the country tight in its grasp. On Wednesday, India recorded single-day rise of 3,60,960 coronavirus cases, which pushed the total tally to 1,79,97,267. Due to unavailability of hospital beds and oxygen cylinders, the country has seen the death toll cross two lakh, following 3,293 fresh fatalities. Corporate India has joined hands to do their bit to tackle the Covid situation better. Deepinder Goyal, CEO of Zomato, took to Twitter to share an update about his Help Save My India campaign via its not-for-profit initiative Zomato Feeding India in association with logistics company Delhivery.

NRN Murthy & Sudha Murty get Covishield jab; Uday Kotak says 1st shot was smooth ; Biocon boss calls vaccine a booster dose

India took a step forward in its fight against the Covid-19 pandemic on Monday as it began the process of administering the vaccine to citizens. With some help from the Hyderabad-based Bharat Biotech s Covaxin - developed with the help of the Indian Council of Medical Research and National Institute of Virology - and Covishield which was jointly processed by the Oxford University, British-Swedish company AstraZeneca, and manufactured by Serum Institute of India (SII) in Pune, the country found hope as pictures of people taking the shots surfaced. The inoculation drive entered its second phase on Monday in which the coverage was expanded to include everyone above 60 and those over 45 with co-morbidities.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.